A dominant-negative p65 PAK peptide inhibits angiogenesis.
about
Hydrogen peroxide formation and actin filament reorganization by Cdc42 are essential for ethanol-induced in vitro angiogenesisHuman immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant productionAIF-1 expression regulates endothelial cell activation, signal transduction, and vasculogenesisp21-activated kinase signaling in breast cancerMolecular mechanisms controlling vascular lumen formation in three-dimensional extracellular matricesActin remodeling by Nck regulates endothelial lumen formationp21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 PathwayNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityEtk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathwayAkt phosphorylation of serine 21 on Pak1 modulates Nck binding and cell migrationPAK signalling during the development and progression of cancerSrc and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness.Polarized actin structural dynamics in response to cyclic uniaxial stretch.Identification of phosphorylation sites in betaPIX and PAK1Matrix-specific protein kinase A signaling regulates p21-activated kinase activation by flow in endothelial cellsp21-activated kinase regulates endothelial permeability through modulation of contractility.Cadherin adhesion, tissue tension, and noncanonical Wnt signaling regulate fibronectin matrix organization.The subendothelial extracellular matrix modulates JNK activation by flowBeta8 integrin binds Rho GDP dissociation inhibitor-1 and activates Rac1 to inhibit mesangial cell myofibroblast differentiation.p21-activated kinase signaling regulates oxidant-dependent NF-kappa B activation by flow.Blocking p21-activated kinase reduces lipopolysaccharide-induced acute lung injury by preventing polymorphonuclear leukocyte infiltration.Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis.Induction of vascular permeability: beta PIX and GIT1 scaffold the activation of extracellular signal-regulated kinase by PAK.Repression of choroidal neovascularization through actin cytoskeleton pathways by microRNA-24.Screening for peptide drugs from the natural repertoire of biodiverse protein folds.p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.Tumor growth and angiogenesis is impaired in CIB1 knockout micePotential compensation among group I PAK members in hindlimb ischemia and wound healing.Evidence for a novel mechanism of the PAK1 interaction with the Rho-GTPases Cdc42 and Rac.Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesisPAK1 as a therapeutic target.Targeted delivery of mutant Raf kinase to neovessels causes tumor regression.Pleiotropic functions of Rho GTPase signaling: a Trojan horse or Achilles' heel for breast cancer treatment?Recruitment of the adaptor protein Nck to PECAM-1 couples oxidative stress to canonical NF-κB signaling and inflammation.p21-Activated kinase 3 (PAK3) protein regulates synaptic transmission through its interaction with the Nck2/Grb4 protein adaptorA betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish.A new role for cofilin in retinal neovascularization.BET Bromodomain Suppression Inhibits VEGF-induced Angiogenesis and Vascular Permeability by Blocking VEGFR2-mediated Activation of PAK1 and eNOSA tale of two Paks.
P2860
Q23924061-08F15308-9944-430A-9801-A510D4993596Q24610688-69A8B003-8BB2-4ED2-94CC-1CF25175D265Q24651945-CBBC4003-E139-4EB5-9C8E-6B7E3DD90E76Q24796768-E5A12336-B6DF-42B9-8E4D-1C1252E7C4BFQ26996223-0A0A8631-E00F-4ED5-9161-BF0E579B342BQ27305490-BC2DBB97-19CA-47FB-A442-E451CB4AA931Q27320786-CA54113F-26B6-440A-A926-E0F0B8E36719Q28166312-4AF2E9F5-5E82-4C26-881A-B6BC66A47C8EQ28207963-A09BEB0A-B940-4F61-B6B8-6E0280827CC1Q28213453-5B51D2D0-495A-4E9C-BC8C-97EDAFA43BBCQ28307460-D07282B1-8B29-4E52-97CE-D239DF57D18BQ30160185-AAD9A449-770D-4481-9E0D-CE46BB7556E9Q30300280-13CB61F3-EE1F-4A26-846A-2C1531CB510BQ30370259-130777DE-B68D-4399-97EB-79D7F0AA4134Q30432582-5F90D33E-D1D6-4798-9F9C-8025712E9031Q30434340-6718F4E4-D647-4196-A67C-0467B3BA8958Q30436899-8905009A-1C1D-4433-8906-2660C68588EAQ30438150-F259361C-548E-49E0-BA0D-1A9E113D9F85Q30439181-F3FCD62B-3BBB-4F71-A959-59BFA84FF713Q30439404-F3AC95AE-4C64-4E32-AF84-C1163F97C654Q30441773-9745C6B3-66A0-4C5D-B9A8-5CC74615DBA5Q30441862-FB5F6988-6832-4747-B4D9-A5263C07534BQ30442993-FA88CD9B-3BF3-4D7A-AF92-B1ADA330576BQ30443409-A1B4E84E-66A5-490D-8CF1-57CDDD9A98A9Q30571075-37598302-7AAF-4CEF-B449-6B5E59DF013EQ33233385-5FAA8E54-FA56-4C68-A014-CC51FA8F9A24Q33745071-D667DFFD-C7C7-4A80-9C3E-26064FFE8732Q34138822-DC37B868-E422-4967-BC80-4C7A2BADD6FBQ34473172-F75049FC-3D70-4B0C-BE57-3821AFE49CB7Q34926820-1C768214-4C51-47B4-80B4-7BA234AFBD0BQ35001515-27A7A882-0A38-4BB8-97F7-4FBC6F219D1BQ35108164-69539446-E80E-43C3-9797-7BF39169CD8AQ35176868-0DB70B87-0A4D-47A0-B000-4FD41C56E755Q35287780-234909E0-CB30-4F95-B1BD-2A7C20813423Q35551178-9271CB06-DC1E-4ABB-86AF-61B061A5E40FQ35562644-C5B713DC-0E4A-4917-9875-64E485E9960CQ35956832-CD1937A2-4BE7-4A2F-8FAE-147A774D7678Q36743883-FAB9B5C3-B8AF-431A-957F-ECE8021D22CCQ36764845-3ED27639-7F36-471E-B753-6ADE68A6043FQ37058519-76F82E4A-5700-41D9-AFE1-B1F80CE7AA1C
P2860
A dominant-negative p65 PAK peptide inhibits angiogenesis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A dominant-negative p65 PAK peptide inhibits angiogenesis.
@ast
A dominant-negative p65 PAK peptide inhibits angiogenesis.
@en
type
label
A dominant-negative p65 PAK peptide inhibits angiogenesis.
@ast
A dominant-negative p65 PAK peptide inhibits angiogenesis.
@en
prefLabel
A dominant-negative p65 PAK peptide inhibits angiogenesis.
@ast
A dominant-negative p65 PAK peptide inhibits angiogenesis.
@en
P2093
P1433
P1476
A dominant-negative p65 PAK peptide inhibits angiogenesis
@en
P2093
David A Cheresh
Mary E Gerritsen
Nazilla Alderson
William B Kiosses
P304
P356
10.1161/01.RES.0000014227.76102.5D
P577
2002-04-01T00:00:00Z